The aim of this study was to assess the expression of the transcription factor LSF and TSG101 during the neoplastic transformation of endometrial cells and to answer the question of whether the analyses of the expression of TSG101 and LSF could have practical applications as prognostic factors in patients with endometrial cancer. This evidence concerns the gene TFCP2 and endometrial cancer.